Cognex Corporation (NASDAQ:CGNX) shares reached a new 52-week high on Monday . The company traded as high as $119.92 and last traded at $119.96, with a volume of 225,165 shares changing hands. The stock had previously closed at $118.29.

A number of research firms have weighed in on CGNX. Cowen and Company reaffirmed an “outperform” rating and issued a $135.00 price objective (up from $100.00) on shares of Cognex Corporation in a research note on Tuesday, August 8th. BidaskClub raised shares of Cognex Corporation from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 4th. Wolfe Research began coverage on shares of Cognex Corporation in a research note on Tuesday, July 11th. They issued a “peer perform” rating on the stock. Finally, Zacks Investment Research raised shares of Cognex Corporation from a “hold” rating to a “buy” rating and set a $118.00 price objective on the stock in a research note on Wednesday, August 2nd. Six investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $82.75.

The firm’s 50-day moving average price is $111.90 and its 200-day moving average price is $96.56. The stock has a market cap of $10.45 billion, a P/E ratio of 55.16 and a beta of 1.42.

Cognex Corporation (NASDAQ:CGNX) last announced its quarterly earnings results on Monday, July 31st. The scientific and technical instruments company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.08. The company had revenue of $172.90 million for the quarter, compared to analysts’ expectations of $169.79 million. Cognex Corporation had a net margin of 33.10% and a return on equity of 19.51%. Cognex Corporation’s revenue was up 17.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.50 EPS. On average, equities research analysts predict that Cognex Corporation will post $2.55 EPS for the current fiscal year.

In other Cognex Corporation news, CEO Robert Willett sold 25,000 shares of the company’s stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $103.37, for a total transaction of $2,584,250.00. Following the transaction, the chief executive officer now owns 25,000 shares in the company, valued at approximately $2,584,250. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Patrick Alias sold 5,000 shares of the company’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $111.31, for a total transaction of $556,550.00. Following the transaction, the director now owns 5,000 shares in the company, valued at approximately $556,550. The disclosure for this sale can be found here. Insiders have sold a total of 126,750 shares of company stock worth $13,242,726 in the last 90 days. Company insiders own 5.60% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. AHL Partners LLP lifted its stake in Cognex Corporation by 0.8% during the 2nd quarter. AHL Partners LLP now owns 2,842 shares of the scientific and technical instruments company’s stock valued at $241,000 after acquiring an additional 23 shares during the period. Bronfman E.L. Rothschild L.P. lifted its stake in Cognex Corporation by 2.4% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,999 shares of the scientific and technical instruments company’s stock valued at $170,000 after acquiring an additional 47 shares during the period. Sawtooth Solutions LLC lifted its stake in Cognex Corporation by 1.3% during the 2nd quarter. Sawtooth Solutions LLC now owns 4,009 shares of the scientific and technical instruments company’s stock valued at $340,000 after acquiring an additional 51 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Cognex Corporation by 0.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,645 shares of the scientific and technical instruments company’s stock valued at $1,074,000 after acquiring an additional 75 shares during the period. Finally, BB&T Corp lifted its stake in Cognex Corporation by 2.0% during the 2nd quarter. BB&T Corp now owns 4,661 shares of the scientific and technical instruments company’s stock valued at $395,000 after acquiring an additional 92 shares during the period. Institutional investors and hedge funds own 87.24% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Cognex Corporation (CGNX) Sets New 52-Week High at $119.92” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/10/18/cognex-corporation-cgnx-sets-new-52-week-high-at-119-92.html.

Cognex Corporation Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Receive News & Stock Ratings for Cognex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Corporation and related stocks with our FREE daily email newsletter.